{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T17:24:40Z","timestamp":1783790680132,"version":"3.55.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,13]],"date-time":"2020-01-13T00:00:00Z","timestamp":1578873600000},"content-version":"vor","delay-in-days":2234,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["01KN1106"],"award-info":[{"award-number":["01KN1106"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpsmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pain and Symptom Management"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.jpainsymman.2013.02.019","type":"journal-article","created":{"date-parts":[[2013,6,4]],"date-time":"2013-06-04T01:00:38Z","timestamp":1370307638000},"page":"874-886","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":64,"title":["Fentanyl for the Relief of Refractory Breathlessness: A Systematic Review"],"prefix":"10.1016","volume":"46","author":[{"given":"Steffen T.","family":"Simon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peyla","family":"K\u00f6skeroglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Gaertner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond","family":"Voltz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpainsymman.2013.02.019_bib1","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1164\/rccm.201111-2042ST","article-title":"An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea","volume":"185","author":"Parshall","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jpainsymman.2013.02.019_bib2","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1017\/S1478951503030499","article-title":"Breathlessness in cancer and chronic obstructive pulmonary disease: using a qualitative approach to describe the experience of patients and carers","volume":"1","author":"Booth","year":"2003","journal-title":"Palliat Support Care"},{"key":"10.1016\/j.jpainsymman.2013.02.019_bib3","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1017\/S1478951507000454","article-title":"Experiences of breathlessness: a systematic review of the qualitative literature","volume":"5","author":"Gysels","year":"2007","journal-title":"Palliat Support Care"},{"key":"10.1016\/j.jpainsymman.2013.02.019_bib4","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1378\/chest.89.2.234","article-title":"Dyspnea in terminally ill cancer patients","volume":"89","author":"Reuben","year":"1986","journal-title":"Chest"},{"key":"10.1016\/j.jpainsymman.2013.02.019_bib5","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.jpainsymman.2009.01.006","article-title":"A\u00a0community population survey of prevalence and severity of dyspnea in adults","volume":"38","author":"Currow","year":"2009","journal-title":"J\u00a0Pain Symptom Manage"},{"key":"10.1016\/j.jpainsymman.2013.02.019_bib6","first-page":"S37","article-title":"Characteristics of patients with breathlessness\u2014a German national survey on palliative care in-patient units","volume":"24","author":"Altfelder","year":"2010","journal-title":"Palliat Med"},{"key":"10.1016\/j.jpainsymman.2013.02.019_bib7","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1586\/17476348.3.1.21","article-title":"Pharmacological treatment of refractory breathlessness","volume":"3","author":"Booth","year":"2009","journal-title":"Expert Rev Respir Med"},{"key":"10.1016\/j.jpainsymman.2013.02.019_bib8","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1089\/jpm.2008.0158","article-title":"Characteristics and correlates of dyspnea in patients with advanced cancer","volume":"12","author":"Reddy","year":"2009","journal-title":"J\u00a0Palliat Med"},{"key":"10.1016\/j.jpainsymman.2013.02.019_bib9","first-page":"CD002066","article-title":"Opioids for the palliation of breathlessness in terminal illness","volume":"4","author":"Jennings","year":"2001","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jpainsymman.2013.02.019_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bmj.327.7414.523","article-title":"Randomised, double blind, placebo-controlled crossover trial of sustained release morphine for the management of refractory dyspnoea","volume":"327","author":"Abernethy","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.jpainsymman.2013.02.019_bib11","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.jpainsymman.2012.06.008","article-title":"Episodic and continuous breathlessness\u2014a new categorization of breathlessness","volume":"45","author":"Simon","year":"2013","journal-title":"J\u00a0Pain Symptom Manage"},{"key":"10.1016\/j.jpainsymman.2013.02.019_bib12","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/j.1533-2500.2007.00157.x","article-title":"Effervescent morphine results in faster relief of breakthrough pain in patients compared to immediate release morphine sulfate tablet","volume":"7","author":"Freye","year":"2007","journal-title":"Pain Pract"},{"key":"10.1016\/j.jpainsymman.2013.02.019_bib13","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.ejpain.2010.12.004","article-title":"Multi-centre European study of breakthrough cancer pain: pain characteristics and patient perceptions of current and potential management strategies","volume":"15","author":"Davies","year":"2011","journal-title":"Eur J Pain"},{"key":"10.1016\/j.jpainsymman.2013.02.019_bib14","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ejpain.2008.06.014","article-title":"The management of cancer-related breakthrough pain: recommendations of a task group of the Science Committee of the Association for Palliative Medicine of Great Britain and Ireland","volume":"13","author":"Davies","year":"2009","journal-title":"Eur J Pain"},{"key":"10.1016\/j.jpainsymman.2013.02.019_bib15","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1586\/ern.11.63","article-title":"Fentanyl for breakthrough pain: a systematic review","volume":"11","author":"Davis","year":"2011","journal-title":"Expert Rev Neurother"},{"key":"10.1016\/j.jpainsymman.2013.02.019_bib16","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jclinepi.2009.06.006","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"62","author":"Liberati","year":"2009","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.jpainsymman.2013.02.019_bib17","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jpainsymman.2005.10.002","article-title":"Oral transmucosal fentanyl citrate in the management of dyspnea crises in cancer patients","volume":"30","author":"Benitez-Rosario","year":"2005","journal-title":"J\u00a0Pain Symptom Manage"},{"key":"10.1016\/j.jpainsymman.2013.02.019_bib18","article-title":"Effects of nebulised fentanyl in patients with refractory dyspnea","volume":"39","author":"Burburan","year":"2009","journal-title":"Eur J Palliat Care"},{"key":"10.1016\/j.jpainsymman.2013.02.019_bib19","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0885-3924(01)00391-8","article-title":"Nebulized fentanyl citrate improves patients' perception of breathing, respiratory rate, and oxygen saturation in dyspnea","volume":"23","author":"Coyne","year":"2002","journal-title":"J\u00a0Pain Symptom Manage"},{"key":"10.1016\/j.jpainsymman.2013.02.019_bib20","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1089\/jpm.2007.0161","article-title":"Oral transmucosal fentanyl citrate for dyspnea in terminally ill patients: an observational case series","volume":"11","author":"Gauna","year":"2008","journal-title":"J\u00a0Palliat Med"},{"key":"10.1016\/j.jpainsymman.2013.02.019_bib21","first-page":"547","volume":"37","author":"Gika","year":"2010","journal-title":"Gan to kagaku ryoho (Cancer & Chemotherapy)"},{"key":"10.1016\/j.jpainsymman.2013.02.019_bib22","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1159\/000081769","article-title":"Nebulized fentanyl for palliation of dyspnea in a cystic fibrosis patient","volume":"71","author":"Graff","year":"2004","journal-title":"Respiration"},{"key":"10.1016\/j.jpainsymman.2013.02.019_bib23","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.jpainsymman.2011.05.007","article-title":"Inhaled fentanyl citrate improves exercise endurance during high-intensity constant work rate cycle exercise in chronic obstructive pulmonary disease","volume":"43","author":"Jensen","year":"2012","journal-title":"J\u00a0Pain Symptom Manage"},{"key":"10.1016\/j.jpainsymman.2013.02.019_bib24","first-page":"387","article-title":"The use of remifentanil in palliative care","volume":"17","author":"Mercadante","year":"1999","journal-title":"J\u00a0Pain Symptom Manage"},{"key":"10.1016\/j.jpainsymman.2013.02.019_bib25","doi-asserted-by":"crossref","first-page":"88","DOI":"10.2165\/00044011-199816010-00014","article-title":"Transdermal fentanyl in palliative care. A series of five cases","volume":"16","author":"O'Siorain","year":"1998","journal-title":"Clin Drug Investig"},{"key":"10.1016\/j.jpainsymman.2013.02.019_bib26","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1089\/jpm.2009.0113","article-title":"Failure to accrue to a study of nebulized fentanyl for dyspnea: lessons learned","volume":"12","author":"Smith","year":"2009","journal-title":"J\u00a0Palliat Med"},{"key":"10.1016\/j.jpainsymman.2013.02.019_bib27","first-page":"194","volume":"12","author":"Trujillo Vilchez","year":"2005","journal-title":"Medicina Paliativa"},{"key":"10.1016\/j.jpainsymman.2013.02.019_bib28","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1016\/j.jpainsymman.2008.08.002","article-title":"Intranasal fentanyl for episodic breathlessness","volume":"36","author":"Sitte","year":"2008","journal-title":"J\u00a0Pain Symptom Manage"},{"key":"10.1016\/j.jpainsymman.2013.02.019_bib29","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1007\/s10354-009-0724-2","volume":"159","author":"Sitte","year":"2009","journal-title":"Wien Med Wochenschr"},{"key":"10.1016\/j.jpainsymman.2013.02.019_bib30","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.jpainsymman.2010.12.010","article-title":"Fentanyl buccal tablets for breakthrough pain in highly tolerant cancer patients: preliminary data on the proportionality between breakthrough pain dose and background dose","volume":"42","author":"Mercadante","year":"2011","journal-title":"J\u00a0Pain Symptom Manage"},{"key":"10.1016\/j.jpainsymman.2013.02.019_bib31","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.jpainsymman.2010.11.021","article-title":"Once-daily opioids for chronic dyspnea: a dose increment and pharmacovigilance study","volume":"42","author":"Currow","year":"2011","journal-title":"J\u00a0Pain Symptom Manage"},{"key":"10.1016\/j.jpainsymman.2013.02.019_bib32","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.jpainsymman.2006.09.015","article-title":"Symptomatic therapy of dyspnea with strong opioids and its effect on ventilation in palliative care patients","volume":"33","author":"Clemens","year":"2007","journal-title":"J\u00a0Pain Symptom Manage"}],"container-title":["Journal of Pain and Symptom Management"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088539241300239X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088539241300239X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:10:44Z","timestamp":1760130644000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S088539241300239X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S088539241300239X"],"URL":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2013.02.019","relation":{},"ISSN":["0885-3924"],"issn-type":[{"value":"0885-3924","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fentanyl for the Relief of Refractory Breathlessness: A Systematic Review","name":"articletitle","label":"Article Title"},{"value":"Journal of Pain and Symptom Management","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2013.02.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 U.S. Cancer Pain Relief Committee. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}